Just as F1 teams rely on real-time data to optimize performance, IoT is enabling life sciences manufacturers to achieve new ...

Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular ...

An Oakland financier, which sponsored a life sciences-focused blank-check company this summer that grossed $230 million, ...

Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne ...

By engaging with some of the most influential executives in the industry and the many organizations that advocate for them, the series will provide valuable perspectives on the evolving landscape of ...

Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies ...

Life Sciences and Pharma industry leaders are turning to Axtria for cutting-edge solutions that boost field force ...

Shares in Wave rose 53% after the trial data was announced, taking its market cap above the $1 billion threshold. The company ...

Wave’s result is in line with the data that supported accelerated approval of NS Pharma’s exon 53 DMD drug Viltepso. NS ...

India]/ London [UK], September 24: Hexaware Technologies, a provider of IT services and solutions, and PointCross Life ...

Report by Hays compares talent pools in 30 economies across five sectors, such as technology, engineering, manufacturing and ...